Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
about
Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studiesThe clinical application of linagliptin in AsiansIncretins and selective renal sodium-glucose co-transporter 2 inhibitors in hypertension and coronary heart diseaseThe efficacy of vildagliptin concomitant with insulin therapy in type 2 diabetic subjectsDipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment.Linagliptin: an update of its use in patients with type 2 diabetes mellitus.Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials.A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control.Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: subgroup analysis of a randomized clinical trial.A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes.
P2860
Q24568148-6C8E7991-1D1B-493C-B814-D0C49992ACF6Q26781942-D058B8CC-2D14-4EC4-8DE7-37ADB6457E3EQ26784211-38DD4284-48D9-4878-8757-1AA80FF7F15BQ35166849-608901AB-3BF3-4D7D-9A86-929E3D76D276Q38200670-8C6E15DF-A5FD-44EB-9FD8-C097984A5C39Q38258278-F9AA6EAE-2FF5-4822-B1ED-F2D5C4D31A63Q39870068-1FF3BB94-43A6-4EBA-B0AF-E48773172FB0Q41259354-26E85E59-99D8-41ED-AA69-396DB6B5D48DQ41997013-88B43B57-F17C-4549-A029-0470609B119AQ45983099-92444B01-CE2C-4FCB-9B96-591B78F5F012
P2860
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
@en
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
@nl
type
label
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
@en
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
@nl
prefLabel
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
@en
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes
@en
P2093
A Sarashina
H-J Woerle
M von Eynatten
R Kawamori
S Thiemann
P2860
P304
P356
10.1111/DOM.12039
P577
2012-12-07T00:00:00Z